Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLIGENIX, INC. Investor Presentation 2014

Sep 8, 2014

35119_rns_2014-09-08_fcfade8c-e90e-4996-b3c6-a94a67c38de0.zip

Investor Presentation

Open in viewer

Opens in your device viewer

8-K 1 f8k090814_soligenix.htm CURRENT REPORT

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): September 8, 2014

Commission File No. 000-16929

Soligenix, Inc.

(Exact name of small business issuer as specified in its charter)

DELAWARE 41-1505029
(State or
other jurisdiction of incorporation or organization) (I.R.S. Employer
Identification Number)
29
Emmons Drive, Suite
C-10 Princeton,
NJ 08540
(Address of
principal executive offices) (Zip Code)
(609) 538-8200
(Issuer’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

Item 7.01 Regulation FD Disclosure.

Soligenix, Inc. (the “Company”) has updated its corporate presentation as of September 8, 2014. The slides from this presentation are attached hereto as Exhibit 99.1. The attached materials will be presented on September 9, 2014 by the Company’s President and Chief Executive Officer, Christopher J. Schaber, PhD., at the 16th Annual Rodman & Renshaw Global Investment Conference and also will be posted on the Company’s website at www.soligenix.com. The Company does not undertake to update this presentation.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description
99.1 Corporate Presentation.

Field: Page; Sequence: 2

2

Field: /Page

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| /s/
Christopher J. Schaber |
| --- |
| Christopher
J. Schaber, Ph.D. |
| President
and Chief Executive Officer |
| (Principal
Executive Officer) |

Field: Page; Sequence: 3

3

Field: /Page

EXHIBIT INDEX

| Exhibit
No. | Description |
| --- | --- |
| 99.1 | Corporate Presentation. |

4

Field: Rule-Page

Field: /Rule-Page